A sejten kívüli szabad DNS felszabadulásának és degradációjának in vivo elemzése

Translated title of the contribution: In vivo analysis of circulating cell-free DNA release and degradation

Barták Barbara Kinga, Nagy Zsófia Brigitta, Spisák Sándor, Z. Tulassay, Dank Magdolna, P. Igaz, Molnár Béla

Research output: Contribution to journalArticle

Abstract

Introduction: Cell-free DNA (cfDNA) was first detected in human plasma in the 1940s, but the knowledge on its regulation and rate of release is incomplete. CfDNA can originate from both normal and tumour cells. Aim: Our aims were to investigate the rate of cfDNA's release in SHO mice/HT-29 colorectal adenocarcinoma cell line xenograft model and to define the decay of methylated and non-methylated DNA fragments in C57BL/6 bloodstream. Method: SHO mice were xenografted with human HT-29 cells, than blood samples were collected over 2 months. CfDNA was isolated, then quantified by real-time PCR with highly specific genomic and mitochondrial human and mouse primer sets. This method permitted to define the ratio of human/mouse DNA. To assess the degradation rate of cfDNA, 3000 bp sized methylated and non-methylated DNA fragments were injected into healthy and C38 tumour- cell vaccinated C57BL/6 mice's bloodstream. The decay of amplicons was measured with 19 PCR assays. Results: The amount of human DNA until the 2nd week was below the limit of detection. From the third week, a continuous growth was experienced, which reached 18.26% by the 8th week. Moreover, it was found that in healthy animals the non-methylated DNA disappears from the plasma after 6 hours, while the methylated fragment was detectable even after 24 hours. In animals with tumour, both amplicons were detectable after 24 hours. Conclusion: The examination of the role and mechanism of cfDNA shows an increasing level of interest. This work can contribute to a better understanding of the release and degradation of cfDNA.

Original languageHungarian
Pages (from-to)223-233
Number of pages11
JournalOrvosi Hetilap
Volume159
Issue number6
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

DNA
Neoplasms
HT29 Cells
Inbred C57BL Mouse
Heterografts
Limit of Detection
Real-Time Polymerase Chain Reaction
Adenocarcinoma
Cell Line
Polymerase Chain Reaction
Growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A sejten kívüli szabad DNS felszabadulásának és degradációjának in vivo elemzése. / Kinga, Barták Barbara; Brigitta, Nagy Zsófia; Sándor, Spisák; Tulassay, Z.; Magdolna, Dank; Igaz, P.; Béla, Molnár.

In: Orvosi Hetilap, Vol. 159, No. 6, 01.02.2018, p. 223-233.

Research output: Contribution to journalArticle

Kinga, Barták Barbara ; Brigitta, Nagy Zsófia ; Sándor, Spisák ; Tulassay, Z. ; Magdolna, Dank ; Igaz, P. ; Béla, Molnár. / A sejten kívüli szabad DNS felszabadulásának és degradációjának in vivo elemzése. In: Orvosi Hetilap. 2018 ; Vol. 159, No. 6. pp. 223-233.
@article{7c01b41c2020443490c5b71dcad1e146,
title = "A sejten k{\'i}v{\"u}li szabad DNS felszabadul{\'a}s{\'a}nak {\'e}s degrad{\'a}ci{\'o}j{\'a}nak in vivo elemz{\'e}se",
abstract = "Introduction: Cell-free DNA (cfDNA) was first detected in human plasma in the 1940s, but the knowledge on its regulation and rate of release is incomplete. CfDNA can originate from both normal and tumour cells. Aim: Our aims were to investigate the rate of cfDNA's release in SHO mice/HT-29 colorectal adenocarcinoma cell line xenograft model and to define the decay of methylated and non-methylated DNA fragments in C57BL/6 bloodstream. Method: SHO mice were xenografted with human HT-29 cells, than blood samples were collected over 2 months. CfDNA was isolated, then quantified by real-time PCR with highly specific genomic and mitochondrial human and mouse primer sets. This method permitted to define the ratio of human/mouse DNA. To assess the degradation rate of cfDNA, 3000 bp sized methylated and non-methylated DNA fragments were injected into healthy and C38 tumour- cell vaccinated C57BL/6 mice's bloodstream. The decay of amplicons was measured with 19 PCR assays. Results: The amount of human DNA until the 2nd week was below the limit of detection. From the third week, a continuous growth was experienced, which reached 18.26{\%} by the 8th week. Moreover, it was found that in healthy animals the non-methylated DNA disappears from the plasma after 6 hours, while the methylated fragment was detectable even after 24 hours. In animals with tumour, both amplicons were detectable after 24 hours. Conclusion: The examination of the role and mechanism of cfDNA shows an increasing level of interest. This work can contribute to a better understanding of the release and degradation of cfDNA.",
keywords = "Cell-free DNA, DNase activity, Plasma, Xenograft model",
author = "Kinga, {Bart{\'a}k Barbara} and Brigitta, {Nagy Zs{\'o}fia} and Spis{\'a}k S{\'a}ndor and Z. Tulassay and Dank Magdolna and P. Igaz and Moln{\'a}r B{\'e}la",
year = "2018",
month = "2",
day = "1",
doi = "10.1556/650.2018.30929",
language = "Hungarian",
volume = "159",
pages = "223--233",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "6",

}

TY - JOUR

T1 - A sejten kívüli szabad DNS felszabadulásának és degradációjának in vivo elemzése

AU - Kinga, Barták Barbara

AU - Brigitta, Nagy Zsófia

AU - Sándor, Spisák

AU - Tulassay, Z.

AU - Magdolna, Dank

AU - Igaz, P.

AU - Béla, Molnár

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Introduction: Cell-free DNA (cfDNA) was first detected in human plasma in the 1940s, but the knowledge on its regulation and rate of release is incomplete. CfDNA can originate from both normal and tumour cells. Aim: Our aims were to investigate the rate of cfDNA's release in SHO mice/HT-29 colorectal adenocarcinoma cell line xenograft model and to define the decay of methylated and non-methylated DNA fragments in C57BL/6 bloodstream. Method: SHO mice were xenografted with human HT-29 cells, than blood samples were collected over 2 months. CfDNA was isolated, then quantified by real-time PCR with highly specific genomic and mitochondrial human and mouse primer sets. This method permitted to define the ratio of human/mouse DNA. To assess the degradation rate of cfDNA, 3000 bp sized methylated and non-methylated DNA fragments were injected into healthy and C38 tumour- cell vaccinated C57BL/6 mice's bloodstream. The decay of amplicons was measured with 19 PCR assays. Results: The amount of human DNA until the 2nd week was below the limit of detection. From the third week, a continuous growth was experienced, which reached 18.26% by the 8th week. Moreover, it was found that in healthy animals the non-methylated DNA disappears from the plasma after 6 hours, while the methylated fragment was detectable even after 24 hours. In animals with tumour, both amplicons were detectable after 24 hours. Conclusion: The examination of the role and mechanism of cfDNA shows an increasing level of interest. This work can contribute to a better understanding of the release and degradation of cfDNA.

AB - Introduction: Cell-free DNA (cfDNA) was first detected in human plasma in the 1940s, but the knowledge on its regulation and rate of release is incomplete. CfDNA can originate from both normal and tumour cells. Aim: Our aims were to investigate the rate of cfDNA's release in SHO mice/HT-29 colorectal adenocarcinoma cell line xenograft model and to define the decay of methylated and non-methylated DNA fragments in C57BL/6 bloodstream. Method: SHO mice were xenografted with human HT-29 cells, than blood samples were collected over 2 months. CfDNA was isolated, then quantified by real-time PCR with highly specific genomic and mitochondrial human and mouse primer sets. This method permitted to define the ratio of human/mouse DNA. To assess the degradation rate of cfDNA, 3000 bp sized methylated and non-methylated DNA fragments were injected into healthy and C38 tumour- cell vaccinated C57BL/6 mice's bloodstream. The decay of amplicons was measured with 19 PCR assays. Results: The amount of human DNA until the 2nd week was below the limit of detection. From the third week, a continuous growth was experienced, which reached 18.26% by the 8th week. Moreover, it was found that in healthy animals the non-methylated DNA disappears from the plasma after 6 hours, while the methylated fragment was detectable even after 24 hours. In animals with tumour, both amplicons were detectable after 24 hours. Conclusion: The examination of the role and mechanism of cfDNA shows an increasing level of interest. This work can contribute to a better understanding of the release and degradation of cfDNA.

KW - Cell-free DNA

KW - DNase activity

KW - Plasma

KW - Xenograft model

UR - http://www.scopus.com/inward/record.url?scp=85041489238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041489238&partnerID=8YFLogxK

U2 - 10.1556/650.2018.30929

DO - 10.1556/650.2018.30929

M3 - Article

C2 - 29400102

AN - SCOPUS:85041489238

VL - 159

SP - 223

EP - 233

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 6

ER -